Austin Health

Title
Gut microbiota - a double-edged sword in cancer immunotherapy.
Publication Date
2023
Author(s)
Andrews, Miles C
Vasanthakumar, Ajithkumar
Type of document
Journal Article
DOI
10.1016/j.trecan.2022.08.003
Abstract
Immune checkpoint blockade (ICB) has revolutionized cancer treatment. However, many patients fail to respond to this therapy or experience side effects. Recently, gut microbiota have emerged as a key determinant of ICB efficacy and toxicity, making manipulation of the microbiome a novel therapeutic strategy with which to improve ICB outcomes.
Link
link
Citation
Trends in Cancer 2023; 9(1)
Jornal Title
Trends in Cancer

Files:

NameSizeformatDescriptionLink